Johnson & Johnson (JNJ)
NYSE: JNJ · IEX Real-Time Price · USD
154.64
+0.36 (0.23%)
At close: May 17, 2024, 4:00 PM
154.82
+0.18 (0.12%)
After-hours: May 17, 2024, 7:39 PM EDT

Johnson & Johnson Revenue

Johnson & Johnson had revenue of $81.80B in the twelve months ending March 31, 2024, with 5.60% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $21.38B with 2.34% year-over-year growth. In the year 2023, Johnson & Johnson had annual revenue of $85.16B with 6.46% growth.

Revenue (ttm)
$81.80B
Revenue Growth
+5.60%
P/S Ratio
4.55
Revenue / Employee
$620,136
Employees
131,900
Market Cap
372.19B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202385.16B5.17B6.46%
Jan 1, 202379.99B1.25B1.59%
Jan 2, 202278.74B-3.84B-4.65%
Jan 3, 202182.58B525.00M0.64%
Dec 29, 201982.06B478.00M0.59%
Dec 30, 201881.58B5.13B6.71%
Dec 31, 201776.45B4.56B6.34%
Jan 1, 201771.89B1.82B2.59%
Jan 3, 201670.07B-4.26B-5.73%
Dec 28, 201474.33B3.02B4.23%
Dec 29, 201371.31B4.09B6.08%
Dec 30, 201267.22B2.19B3.37%
Jan 1, 201265.03B3.44B5.59%
Jan 2, 201161.59B-310.00M-0.50%
Jan 3, 201061.90B-1.85B-2.90%
Dec 28, 200863.75B2.65B4.34%
Dec 30, 200761.10B7.77B14.57%
Dec 31, 200653.32B2.81B5.56%
Jan 1, 200650.51B3.17B6.69%
Jan 2, 200547.35B5.49B13.10%
Dec 28, 200341.86B5.56B15.33%
Dec 29, 200236.30B3.98B12.32%
Dec 30, 200132.32B3.15B10.78%
Dec 31, 200029.17B1.17B4.16%
Dec 30, 199928.01B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 379.49B
Merck & Co. 61.40B
AbbVie 54.40B
Novartis AG 49.92B
AstraZeneca 47.61B
Thermo Fisher 42.49B
Abbott Laboratories 40.33B
Eli Lilly 35.93B
Revenue Rankings